Serum amyloid A-luciferase transgenic mice: Response to sepsis, acute arthritis, and contact hypersensitivity and the effects of proteasome inhibition

Journal of Immunology

Volumn 174, Issue 12, 2005, Pages 8125-8134

  Zhang, Ning ^a   Ahsan, Muhammad H ^a   Purchio, Anthony F ^a   West, David B ^a  

^a Xenogen   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; OXAZOLONE; PROTEASOME; PROTEASOME INHIBITOR; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CHRONIC INFLAMMATION; CONTACT ALLERGY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; EX VIVO STUDY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMAGING SYSTEM; INFLAMMATORY DISEASE; KNEE; LIVER; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINASE INHIBITION; RNA ANALYSIS; SAA1 GENE; SEPSIS; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

EID: 20444389826     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.12.8125     Document Type: Article

References (32)

1. Jensen, L. E., and A. S. Whitehead. 1998. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem. J. 334: 489-503.
2. Uhlar, C. M., and A. S. Whitehead. 1999. Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 265: 501-523.
3. Meek, R. L., and E. P. Benditt. 1986. Amyloid A gene family expression in different mouse tissues. J. Exp. Med. 164: 2006-2017.
4. Ray, A., H. Schatten, and B. K. Ray. 1999. Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J. Biol. Chem. 274: 4300-4308.
5. Thorn, C. F., and A. S. Whitehead. 2002. Differential transcription of the mouse acute phase serum amyloid A genes in response to pro-inflammatory cytokines. Amyloid 9: 229-236.
6. Ganapathi, M. K., D. Rzewnicki, D. Samols, S. L. Jiang, and I. Kushner. 1991. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in HEP 3B cells. J. Immunol. 147: 1261-1265.
7. Li, X., and W. S. Liao. 1992. Cooperative effects of C/EBP-like and KF-B-like binding sites on rat serum amyloid A1 gene expression in liver cells. Nucleic Acids Res. 20: 4765-4772.
8. Ray, A., M. Hannink, and B. K. Ray. 1995. Concerted participation of NF-B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver. J. Biol. Chem. 31: 7365-7374.
9. Xia, C., J. K. Cheshire, H. Patel, and P. Woo. 1997. Cross-talk between transcription factors NF-B and C/EBP in the transcriptional regulation of genes. Int. J. Biochem. Cell. Biol. 29: 1525-1539.
10. Ren, Y., and W. S. Liao. 2001. Transcription factor AP-2 functions as a repressor that contributes to the liver-specific expression of serum amyloid A1 gene. J. Biol. Chem. 276: 17770-17778.
11. Ray, B. K., and A. Ray. 1997. Induction of serum amyloid A (SAA) gene by SAA-activating sequence-binding factor (SAF) in monocyte/macrophage cells: evidence for a functional synergy between SAF and Sp1. J. Biol. Chem. 14: 28948-28953.
12. Ghezzi, P., and J. D. Sipe. 1988. Dexamethasone modulation of LPS, IL-1, and TNF stimulated serum amyloid A synthesis in mice. Lymphokine Res. 7: 157-166.
13. Ko, A., T. Takii, T. Matsumura, and K. Onozaki. 1999. Augmentation of type I IL-1 receptor and IL-1 signaling by IL-6 and glucocorticoid in murine hepatocytes. J. Immunol. 162: 4260-4265.
14. Schmidt, U., H. Wagner, and T. Miethke. 1999. CpG-DNA upregulates the major acute-phase proteins SAA and SAP. Cell. Microbiol. 1: 61-67.
15. Sukenik, S., J. Henkin, S. Zimlichman, A. Skibin, L. Neuman, M. Pras, J. Horowitz, and R. Shainkin-Kestenbaum. 1988. Serum and synovial fluid levels of serum amyloid A protein and C-reactive protein in inflammatory and noninflammatory arthritis. J. Rheumatol. 15: 942-945.
16. Kumon, Y., T. Suehiro, K. Hashimoto, K. Nakatani, and J. D. Sipe. 1999. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J. Rheumatol. 26: 785-790.
17. Mitchell, T. I., C. I. Coon, and C. E. Brinckerhoff. 1991. Serum amyloid A (SAA3) produced by rabbit synovial fibroblasts treated with phorbol esters or interleukin 1 induces synthesis of collagenase and is neutralized with specific antiserum. J. Clin. Invest. 87: 1177-1185.
18. Vallon, R., F. Freuler, N. Desta-Tsedu, A. Robeva, J. Dawson, P. Wenner, P. Engelhardt, L. Boes, J. Schnyder, C. Tschopp, et al. 2001. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J. Immunol. 166: 2801-2807.
19. McNiff, P. A., C. Stewart, J. Sullivan, H. J. Showell, and C. A. Gabel. 1995. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1β and IL-6 to promote production of serum amyloid A by Hep3B cells. Cytokine 7: 209-219.
20. Strissel, K. J., M. T. Girard, J. A. West-Mays, W. B. Rinehart, J. R. Cook, C. E. Brinckerhoff, and M. E. Fini. 1997. Role of serum amyloid A as an intermediate in the IL-1 and PMA-stimulated signaling pathways regulating expression of rabbit fibroblast collagenase. Exp. Cell Res. 237: 275-287.
21. Meek, R. L., S. Urieli-Shoval, and E. P. Benditt. 1994. Expression of Apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc. Natl. Acad. Sci. USA 91: 3186-3190.
22. Vreugdenhil, A. C., M. A. Dentener, A. M. Snoek, J. W. Greve, and W. A. Buurman. 1999. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response. J. Immunol. 163: 2792-2798.
23. Liang, J. S., J. A. Sloane, J. M. Wells, C. R. Abraham, R. E. Fine, and J. D. Sipe. 1997. Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci. Lett. 225: 73-76.
24. Yamada, T. 1999. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin. Chem. Lab. Med. 37: 381-388.
25. Contag, P. R., I. N. Olomu, D. K. Stevenson, and C. H. Contag. 1998. Bioluminescent indicators in living mammals. Nat. Med. 4: 245-247.
26. Thorn, C. F., and A. S. Whitehead. 2002. Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2. J. Immunol. 169: 399-406.
27. Cunnane, G. 2001. Amyloid precursors and amyloidosis in inflammatory arthritis. Curr. Opin. Rheumatol. 13: 67-73.
28. Kisilevsky, R. 2000. Amyloids: tombstones or triggers? Nat. Med. 6: 633-634.
29. Williams, R. O., L. Marinova-Mutafchieva, M. Feldmann, and R. N. Maini. 2000. Evaluation of TNF-α and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-α/anti-CD4 therapy. J. Immunol. 165: 7240-7245.
30. Probert, L., D. Plows, G. Kontogeorgos, and G. Kollias. 1995. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur. J. Immunol. 25: 1794-1797.
31. Elliott, M. J. R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, P. Katsikis, F. M. Brennan, J. Walker, H. Bijl, J. Ghrayeb, et al. 1993. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum. 36: 1681-1690.
32. Palmer, G., D. Talabot-Ayer, L. Szalay-Quinodoz, M. Maret, W. P. Arend, and C. Gabay. 2003. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis. Eur. J. Immunol. 33: 434-440.